| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PHGE | Common Stock | Sale | -$2.71 K | -8.1 K | -0.26% | $0.34 | 3.06 M | Oct 17, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$5.29 K | -15.3 K | -0.5% | $0.35 | 3.05 M | Oct 18, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$1.65 K | -4.5 K | -0.15% | $0.37 | 3.04 M | Oct 19, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$2.48 K | -6.64 K | -0.22% | $0.37 | 3.04 M | Oct 20, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$2 K | -5.4 K | -0.18% | $0.37 | 3.03 M | Oct 21, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$2.06 K | -5.9 K | -0.19% | $0.35 | 3.03 M | Oct 24, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$1.12 K | -3.07 K | -0.1% | $0.37 | 3.02 M | Oct 25, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$4.33 K | -12.5 K | -0.41% | $0.35 | 3.01 M | Oct 26, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$548 | -1.51 K | -0.05% | $0.36 | 3.01 M | Oct 27, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$543 | -1.53 K | -0.05% | $0.36 | 3.01 M | Oct 28, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$1.22 K | -3.3 K | -0.11% | $0.37 | 3 M | Oct 31, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$473 | -1.3 K | -0.04% | $0.36 | 3 M | Nov 1, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$867 | -2.42 K | -0.08% | $0.36 | 3 M | Nov 2, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$732 | -2 K | -0.07% | $0.37 | 3 M | Nov 3, 2022 | By SymBiosis, LLC | F1 |
| transaction | PHGE | Common Stock | Sale | -$567 | -1.5 K | -0.05% | $0.38 | 3 M | Nov 4, 2022 | By SymBiosis, LLC | F1 |
Chidozie Ugwumba is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | The shares are directly held by SymBiosis, LLC. |